Alembic Pharmaceuticals US

Alembic Pharmaceuticals US, established in 2011, operates as a key subsidiary of India's oldest pharmaceutical entity, Alembic Pharmaceuticals Ltd. The company is deeply involved in the comprehensive lifecycle of pharmaceutical products, encompassing research, development, manufacturing, and global marketing. Specializing in active pharmaceutical ingredients (APIs) and finished dosage formulations, Alembic Pharmaceuticals US serves the critical needs of the healthcare and pharmaceutical sectors. Its strategic focus on innovation and quality underpins its extensive product portfolio, which includes specialized treatments and newly launched pharmaceutical solutions. The company's operational base is situated in Bridgewater, New Jersey, United States, with a single primary location.

With a dedicated workforce ranging from 500-1,000 employees, Alembic Pharmaceuticals US has solidified its position as a significant player in the pharmaceutical landscape. The company's reach extends internationally, supplying essential pharmaceutical products to over 90 countries worldwide, earning it recognition as one of Asia's most respected pharmaceutical enterprises. This global footprint and commitment to operational excellence are driven by its skilled teams. Meet Alembic Pharmaceuticals US's team to gain insight into the leadership and expertise powering its operations. The company's revenue stands at $19.2M, reflecting its substantial market presence and operational capacity.

Operating within a competitive global market, Alembic Pharmaceuticals US leverages its expertise in pharmaceutical product development, focusing on strengths and dosage forms. Its parent company's legacy, dating back to 1907, provides a strong foundation for its ongoing commitment to advancing healthcare solutions. The company's strategic direction is geared towards continuous innovation in pharmaceutical manufacturing and marketing, ensuring it meets the evolvingView more...